Comment on ‘Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib’...

по Charbonneau, C, Sandin, R
Опубликовано 2010

Standardization of the Methylene Blue Reduction Test by the Use of Methylene Blue Thiocyanate

по Thornton, H. R., Sandin, R. B.
Опубликовано 1935

Evidence for mannose-mediated adherence of Candida albicans to human buccal cells in vitro.

по Sandin, R L, Rogers, A L, Patterson, R J, Beneke, E S
Опубликовано 1982

Comparison of the Vitek Immunodiagnostic Assay System with an indirect immunoassay (Toxostat Test Kit) for detection of immunoglobulin G antibodies to Toxoplasma gondii in clinical...

по Sandin, R L, Knapp, C C, Hall, G S, Washington, J A, Rutherford, I
Опубликовано 1991

One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge.

по Michaelsen, T E, Brekke, O H, Aase, A, Sandin, R H, Bremnes, B, Sandlie, I
Опубликовано 1994

Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000–2008)

по Wahlgren, T, Harmenberg, U, Sandström, P, Lundstam, S, Kowalski, J, Jakobsson, M, Sandin, R, Ljungberg, B
Опубликовано 2013

Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study

по Beisland C, Johannesen TB, Klepp O, Axcrona U, Torgersen KM, Kowalski J, Solli O, Sandin R, Oldenburg J
Опубликовано 2017-01-01